Low density lipoprotein receptor mRNA exosomes

N/A

Report date: 2026/03/27 20:01:50

Base Information

Drug NameLow density lipoprotein receptor mRNA exosomes
Drug Alias NameExo-LDLR
ClassificationBiologics > ExosomesCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHyperlipoproteinemia Type II
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesThe Second Affiliated Hospital of the Air Force Medical University of the Chinese People's Liberation Army
China Registration ClassN/A

Develop Information

Active CompaniesThe Second Affiliated Hospital of the Air Force Medical University of the Chinese People's Liberation Army
Inactive CompaniesN/A
Active IndicationsHyperlipoproteinemia Type II
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A